Bioavailability of trospium chloride after intravesical instillation in patients with neurogenic lower urinary tract dysfunction: A pilot study.

Author: BihrA M, GrosseJ, KramerG, SchulzH U, SchwantesU, StöhrerM, WalterP

Paper Details 
Original Abstract of the Article :
Oral drug treatment of detrusor overactivity often causes undesirable side effects in other organs. For some patients, in particular those with neurogenically induced detrusor overactivity (detrusor hyperreflexia), the tolerance level for adverse effects is low and oral treatment may become ineffect...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/(sici)1520-6777(1999)18:5<447::aid-nau6>3.0.co;2-q

データ提供:米国国立医学図書館(NLM)

Intravesical Trospium Chloride: A New Route to Bladder Control

Navigating the challenges of neurogenic lower urinary tract dysfunction can feel like traversing a desert with shifting sands, making bladder control unpredictable and challenging. This study investigates the potential of intravesical trospium chloride, a medication typically administered orally, as a new approach to treating detrusor overactivity. The authors conducted a pilot study, involving six men with spinal cord lesions, to assess the bioavailability of trospium chloride after intravesical instillation. They found that the drug was not absorbed into the circulation in significant amounts, suggesting a potential for targeted treatment with fewer systemic side effects.

A Targeted Approach to Bladder Control

The study's findings suggest that intravesical trospium chloride may be a promising alternative to oral administration for treating detrusor overactivity, offering a more targeted approach with potentially fewer side effects.

Finding Stability in the Shifting Sands of Bladder Control

This study provides a glimpse into the potential of intravesical trospium chloride, but further research is needed to confirm its effectiveness and optimize its use. However, it holds promise for offering a new path to improved bladder control for those navigating the challenges of neurogenic lower urinary tract dysfunction.

Dr.Camel's Conclusion

Intravesical trospium chloride offers a potential new route to bladder control, targeting the bladder directly with fewer systemic side effects. However, further research is essential to fully understand its long-term benefits and confirm its efficacy in a larger patient population.
Date :
  1. Date Completed 1999-11-16
  2. Date Revised 2019-11-03
Further Info :

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.